<DOC>
	<DOCNO>NCT01550549</DOCNO>
	<brief_summary>This study investigate performance physician reader train read florbetapir-PET scan use electronic medium training .</brief_summary>
	<brief_title>Evaluation Web-based Training Educate Physicians Methods Interpreting Florbetapir-PET Scans</brief_title>
	<detailed_description>Avid previously develop florbetapir-PET scan binary read methodology train program , successfully applied study 18F-AV-45-A08 ( NCT01565369 ) , 18F-AV-45-A09 ( NCT01565382 ) 18F-AV-45-A16 ( NCT01447719 ) . In previous study , train conduct in-person . Study 18F-AV-45-PT01 evaluate automate version train program suitable web-based distribution . Nuclear medicine physician complete automate train program read florbetapir-PET image 151 subject repeat reading 33 randomly select image . Readers rate case either positive significant tracer accumulation cortical gray matter negative significant tracer accumulation cortical gray matter . The inter-rater reliability , sensitivity specificity reader evaluate . The primary image set determination inter-reader agreement comprise image 119 subject two previous clinical study ( A07 [ NCT00857415 ] /A16 [ NCT01447719 ] A05 [ NCT00702143 ] ) . This include 59 subject come autopsy Study A07 ( NCT00857415 ) 's follow-up study , A16 ( NCT01447719 ) , set 60 case randomly select Study A05 ( NCT00702143 ) subject , include 20 cognitively-normal control , 20 mild cognitive impairment ) MCI , 20 AD . Subsequently , protocol amend include remain A05 ( NCT00702143 ) MCI patient use train program ( n=32 ) ; 13 32 scan present repeat reading ( increase number A05 MCI case repeat read 20 ) . This increase number unique case validation dataset 151 scan 33 scan repeat yield total 184 scan review reader .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Neurodegenerative Diseases</mesh_term>
	<criteria>Eligibility subject scan use study determine subject 's eligibility/enrollment Study A05 ( NCT00702143 ) A07 ( NCT00857415 ) . Alzheimer 's disease ( AD ) group key eligibility criterion ( Study A05 [ NCT00702143 ] ) : Male female least 50 year age Have probable AD per National Institute Neurological Communication Disorders Stroke ( NINCDS ) criteria Mini mental state exam ( MMSE ) score 10 24 inclusive Mild cognitive impairment group key eligibility criterion ( Study A05 [ NCT00702143 ) : Male female least 50 year age Complaints memory cognitive decline corroborate informant Clinical dementia rating 0.5 No obvious cause cognitive impairment ( eg , head trauma stroke ) Cognitive impairment onset within past year MMSE score great 24 Cognitively normal volunteer group key eligibility criterion ( Study A05 [ NCT00702143 ] ) : Male female least 50 year age MMSE score great equal 29 cognitively normal informant report psychometric test battery screen Autopsy cohort key eligibility criterion ( Study A07 [ NCT00857415 ] ) : Male female 18 year old Projected life expectancy le 6 month Consent brain donation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Amyloid imaging</keyword>
	<keyword>Positron Emission Tomography</keyword>
	<keyword>18F-AV-45</keyword>
	<keyword>florbetapir F 18</keyword>
	<keyword>Diagnostic imaging</keyword>
</DOC>